1. Arencibia, Jose M, Martín, Susana, Pérez-Rodríguez, Francisco J, Bonnin, Ana. . Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer. In International journal of oncology, 34, 457-63. doi:. https://pubmed.ncbi.nlm.nih.gov/19148481/
2. Rudnytska, Olha V, Kulish, Yuliia V, Khita, Olena O, Trufanova, Dariia D, Minchenko, Oleksandr H. 2022. Exposure to nanographene oxide induces gene expression dysregulation in normal human astrocytes. In Endocrine regulations, 56, 216-226. doi:10.2478/enr-2022-0023. https://pubmed.ncbi.nlm.nih.gov/35843713/
3. Jiang, Han, Santos, Herbert J, Nozaki, Tomoyoshi. 2024. Tetraspanin-enriched microdomains play an important role in pathogenesis in the protozoan parasite Entamoeba histolytica. In PLoS pathogens, 20, e1012151. doi:10.1371/journal.ppat.1012151. https://pubmed.ncbi.nlm.nih.gov/39361713/
4. Wang, Haofei, Liu, Zhen, Peng, Zesheng, Fu, Peng, Jiang, Xiaobing. 2025. Identification and validation of TSPAN13 as a novel temozolomide resistance-related gene prognostic biomarker in glioblastoma. In PloS one, 20, e0316552. doi:10.1371/journal.pone.0316552. https://pubmed.ncbi.nlm.nih.gov/39903772/
5. Li, Peng, Dong, Mingqiang, Wang, Zhigang. 2019. Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC). In Bosnian journal of basic medical sciences, 19, 146-154. doi:10.17305/bjbms.2018.2865. https://pubmed.ncbi.nlm.nih.gov/30114378/
6. Wang, Ya-Wen, Zhao, Song, Yuan, Xun-Yi, Zhu, Jiang, Ma, Rong. 2019. miR-4732-5p promotes breast cancer progression by targeting TSPAN13. In Journal of cellular and molecular medicine, 23, 2549-2557. doi:10.1111/jcmm.14145. https://pubmed.ncbi.nlm.nih.gov/30701690/